Literature DB >> 8598802

False-positive Lyme disease serology in human granulocytic ehrlichiosis.

G P Wormser, H W Horowitz, J S Dumler, I Schwartz, M Aguero-Rosenfeld.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8598802     DOI： 10.1016/s0140-6736(96)91475-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State.

Authors:  S J Wong; G S Brady; J S Dumler
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Efficacy of an OspA vaccine preparation for prevention of Lyme disease in New York State.

Authors:  G P Wormser; J Nowakowski; R B Nadelman; I Schwartz; D McKenna; D Holmgren; M Aguero-Rosenfeld
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

3.  Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection.

Authors:  Y Q Zhang; D Mathiesen; C P Kolbert; J Anderson; R T Schoen; E Fikrig; D H Persing
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Human disease in Europe caused by a granulocytic Ehrlichia species.

Authors:  M Petrovec; S Lotric Furlan; T A Zupanc; F Strle; P Brouqui; V Roux; J S Dumler
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.

Authors:  F T Liang; A C Steere; A R Marques; B J Johnson; J N Miller; M T Philipp
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

6.  Heat shock protein 70 of the agent of human granulocytic ehrlichiosis binds to Borrelia burgdorferi antibodies.

Authors:  J W Ijdo; Y Zhang; M L Anderson; D Goldberg; E Fikrig
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

7.  Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteins.

Authors:  M J Lodes; R Mohamath; L D Reynolds; P McNeill; C P Kolbert; E S Bruinsma; D R Benson; E Hofmeister; S G Reed; R L Houghton; D H Persing
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

8.  Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups.

Authors:  V Fingerle; J L Goodman; R C Johnson; T J Kurtti; U G Munderloh; B Wilske
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

9.  Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis.

Authors:  N Zhi; N Ohashi; Y Rikihisa; H W Horowitz; G P Wormser; K Hechemy
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.

Authors:  Gary P Wormser; Maria E Aguero-Rosenfeld; Mary E Cox; John Nowakowski; Robert B Nadelman; Diane Holmgren; Donna McKenna; Susan Bittker; Lois Zentmaier; Denise Cooper; Dionysios Liveris; Ira Schwartz; Harold W Horowitz
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.